Detalles de la búsqueda
1.
CHOP compared with CHOP plus granulocyte colony-stimulating factor in elderly patients with aggressive non-Hodgkin's lymphoma.
J Clin Oncol
; 21(16): 3041-50, 2003 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-12915593
2.
Economics and health-related quality of life in antiemetic therapy: recommendations for trial design.
Eur J Cancer
; 36(12): 1522-35, 2000 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-10930800
3.
A cost-utility analysis comparing intensive chemotherapy alone to intensive chemotherapy followed by myeloablative chemotherapy with autologous stem-cell rescue in newly diagnosed patients with stage II/III multiple myeloma; a prospective randomised phase III study.
Eur J Cancer
; 40(8): 1159-69, 2004 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-15110879
4.
Costs of peripheral blood progenitor cell transplantation using whole blood mobilised by filgrastim as compared with autologous bone marrow transplantation in non-Hodgkin's lymphoma.
Pharmacoeconomics
; 15(3): 305-11, 1999 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-10537437
5.
Health related quality of life in patients with multiple myeloma undergoing a double transplantation.
Eur J Haematol
; 74(2): 136-43, 2005 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-15654905
6.
Costs of intensive treatment and follow-up of patients with multiple myeloma.
Anticancer Drugs
; 9(10): 889-97, 1998 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-9890700
7.
Stem cell transplantations in patients with malignant lymphoma: costs in a Dutch university hospital in the period 1984-1995.
J Hematother Stem Cell Res
; 8(6): 619-25, 1999 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-10645769
Resultados
1 -
7
de 7
1
Próxima >
>>